Goineau Sonia, Guillaume Philippe, Castagné Vincent
Porsolt S.A.S., Z.A. de Glatigné, 53940, Le Genest-Saint-Isle, France.
Fundam Clin Pharmacol. 2015 Feb;29(1):86-94. doi: 10.1111/fcp.12086. Epub 2014 Oct 2.
Several methods are used to evaluate gastric emptying (GE) in rats, which is an important endpoint in preclinical drug development. Although phenol red model or monitoring of plasma acetaminophen levels are well-established procedures for GE assessment, their capacity to detect the effects of pharmacological agents has rarely been compared. This study was therefore designed to evaluate clonidine with loperamide and metoclopramide in the two test models. Rats were administered phenol red or acetaminophen test meals. The remaining amount of phenol red in the stomach or the time course of plasma acetaminophen levels was then measured. In the phenol red test, loperamide (8 mg/kg, p.o.) and clonidine (100 μg/kg, s.c.) decreased GE (-88 and -42%, P < 0.001 and P < 0.01, respectively). Metoclopramide (10 mg/kg, s.c.) accelerated GE (+42%, P < 0.01). Loperamide reduced acetaminophen plasma levels (-45% at T15 min, P < 0.05), suggesting a delayed GE. Clonidine and metoclopramide increased acetaminophen plasma levels (+115 and +152% at T15 min, P < 0.05 and P < 0.001, respectively), suggesting an accelerated GE. The three substances did not affect plasma acetaminophen levels when acetaminophen was subcutaneously injected, thereby suggesting that acetaminophen metabolism/excretion was not modified. Whereas the phenol red test allows the evaluation of GE at a single time point, the measurement of plasma acetaminophen levels over the time would appear more informative. Nevertheless, the fact that clonidine, in contrast to expectation, increased plasma acetaminophen levels, suggests that data obtained with the acetaminophen method should be interpreted with caution for new chemical entities susceptible to modify absorption of acetaminophen from the small intestine.
有几种方法用于评估大鼠的胃排空(GE),这是临床前药物开发中的一个重要终点。尽管酚红模型或监测血浆对乙酰氨基酚水平是评估GE的成熟方法,但它们检测药理剂作用的能力很少被比较。因此,本研究旨在在两种测试模型中评估可乐定与洛哌丁胺和甲氧氯普胺的效果。给大鼠喂食酚红或对乙酰氨基酚测试餐。然后测量胃中剩余的酚红量或血浆对乙酰氨基酚水平的时间进程。在酚红测试中,洛哌丁胺(8毫克/千克,口服)和可乐定(100微克/千克,皮下注射)降低了胃排空(分别为-88%和-42%,P<0.001和P<0.01)。甲氧氯普胺(10毫克/千克,皮下注射)加速了胃排空(+42%,P<0.01)。洛哌丁胺降低了血浆对乙酰氨基酚水平(在T15分钟时降低了-45%,P<0.05),表明胃排空延迟。可乐定和甲氧氯普胺增加了血浆对乙酰氨基酚水平(在T15分钟时分别增加了+115%和+152%,P<0.05和P<0.001),表明胃排空加速。当皮下注射对乙酰氨基酚时,这三种物质不影响血浆对乙酰氨基酚水平,因此表明对乙酰氨基酚代谢/排泄未改变。虽然酚红测试允许在单个时间点评估胃排空,但随时间测量血浆对乙酰氨基酚水平似乎更具信息量。然而,与预期相反,可乐定增加了血浆对乙酰氨基酚水平,这一事实表明,对于可能改变对乙酰氨基酚从小肠吸收的新化学实体,用对乙酰氨基酚方法获得的数据应谨慎解释。